ASCO® 2023 Insights: "KEYNOTE-671 Trial Key Learnings & Clinical Implications - Pembro + Chemo Followed by Resection and Adjuvant Pembro for Early NSCLC"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

ASCO® 2023 Insights: "KEYNOTE-671 Trial Key Learnings & Clinical Implications - Pembro + Chemo Followed by Resection and Adjuvant Pembro for Early NSCLC"

By Insights from 2023 ASCO® Annual Meeting FEATURING Jack West

943 views

July 10, 2023

0 Comments

Updates in the Management of NSCLC: Systemic Therapy Year in Review

Feat. W. Iams

57:44

Vogl, NY

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl

35:40

Balazs Halmos

Year in Review: Lung Cancer

17:20

Total Health

2024 Intervention Selection & Sequencing in Early Stage NSCLC

Feat. J. Porter

27:04

Fengting Yan

Cancer Screening Molecular Tools

08:49

David Carbone

The Use of IO Doublet in PD-L1-Negative NSCLC

25:35

Total Health

NGS and Liquid Biopsy: Overcoming Challenges in Widespread Testing

Feat. S. Kazmi

13:19

IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

Duration of Immunotherapy Beyond 2 Years for Patients With Advanced …

Feat. E. Rodriguez

30:27

Insights from 2023 ESMO Annual Meeting

Perioperative Immunotherapy Strategies in Resectable NSCLC After ESM…

Feat. G. Mountzios

09:40

John Conibear

PACIFIC Trial 5-Year OS Data: Clinical Implications in NSCLC

14:49

Vivek Subbiah

Year in Review: Precision Medicine

16:12

Total Health

2024 Updates on the Fast-Changing NSCLC Landscape

Feat. R. Osarogiagbon

05:02

GRACE

Targeted Therapies in Lung Cancer 2023: Biomarkers in NSCLC

Feat. A. Desai

23:32

2023 West Oncology Conference

2023 Updates on Neoadjuvant and Adjuvant NSCLC

Feat. M. Johnson

17:34

ecancer

Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…

Feat. L. Raez

11:50

GRACE

The CheckMate 816 Trial: The Success of Neoadjuvant NSCLC Therapies

Feat. J. Rotow

22:57

Total Health

Lung Cancer Screening - Best of Lung 2023

Feat. C. Olazagasti

20:27

Yale Cancer Center

Progress in the Treatment of NSCLC

Feat. R. Herbst

08:30

Insights from 2023 ESMO Annual Meeting

PAPILLON Study - Amivantamab + Chemo vs. Chemo as 1L Treatment in EG…

Feat. N. Girard

54:26

Yale Cancer Center

Year in Review: Progress in NSCLC Treatment

Feat. R. Herbst

Login

Login

Join VuMedi

ASCO® 2023 Insights: "KEYNOTE-671 Trial Key Learnings & Clinical Implications - Pembro + Chemo Followed by Resection and Adjuvant Pembro for Early NSCLC"

Related Content